Furthermore, as early-onset AD may represent a more “pure” form of AD with relatively few comorbidities compared to late-onset AD [26], we hypothesized that tau pathology and cognitive performance would be more strongly associated in early- vs late-onset AD. This evidence concerns the gene MAPT and Alzheimer disease.